Second quarter 2025 GAAP net income attributable to Intuitive was $658 million, or $1.81 per diluted share, compared with $527 million, or $1.46 per diluted share, in the second quarter of 2024.

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...